FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3196366923> ?p ?o ?g. }

• W3196366923 endingPage "174" @default.
• W3196366923 startingPage "160" @default.
• W3196366923 abstract "Background: One of the leading global metabolic diseases marked by insulin resistance and chronic hyperglycemia is type 2 diabetes mellitus (T2DM). Since the last decade, DPP-4 enzyme inhibition has proven to be a successful, safe, and well-established therapy for the treatment of T2DM. Objective: The present work reports the synthesis, characterization, and screening of some novel 2- methyl-N'-[(Z)-substituted-phenyl ethylidene] imidazo [1, 2-a] pyridine-3-carbohydrazide derivatives as DPP-IV inhibitors for the treatment of T2DM. Methods: The molecular docking was performed to study these derivatives' binding mode in the enzyme's allosteric site. All the synthesized compounds were subjected for DPP-IV enzyme assay and in vivo antihyperglycemic activity in STZ-induced diabetic rats. Results: The synthesized derivatives exhibited potent antidiabetic activity as compared to the standard drug Sitagliptin. Out of sixteen compounds, A1, A4, B4, C2, C3, and D4 have shown promising antidiabetic activity against the DPP-IV enzyme. The most promising compound, C2, showed a percentage inhibition of 72.02±0.27 at 50 μM concentration. On the 21st-day, compound C2 showed a significant reduction in serum blood glucose level, i.e., 156.16±4.87 mg/dL, then diabetic control, which was 280.00±13.29 mg/dL whereas, standard Sitagliptin showed 133.50±11.80 mg/dL. In the in vivo antihyperglycemic activity, the compounds have exhibited good hypoglycemic potential in fasting blood glucose in the T2DM animal model. All the docked molecules have exhibited perfect binding affinity towards the active pocket of the enzyme. The synthesized derivatives were screened through Lipinski's rule of five for better optimization, and fortunately, none of them violated the rule. Conclusion: The above results indicate that compound C2 is a relatively active and selective hit molecule that can be structurally modified to enhance the DPP-IV inhibitor's potency and overall pharmacological profile. From the present work, it has been concluded that substituted pyridine-3-carbohydrazide derivatives possess excellent DPP-IV inhibitory potential and can be better optimized further by generating more in vivo, in vitro models." @default.
• W3196366923 created "2021-09-13" @default.
• W3196366923 creator A5009305444 @default.
• W3196366923 creator A5088699308 @default.
• W3196366923 date "2022-02-01" @default.
• W3196366923 modified "2023-09-26" @default.
• W3196366923 title "Synthesis, Characterization and Screening of Some Novel 2-Methyl-N'- [(Z)-Substituted-Phenyl ethylidene] Imidazo [1, 2-a] Pyridine-3-Carbohy drazide Derivatives as DPP-IV Inhibitors for the Treatment of Type 2 Diabetes Mellitus" @default.
• W3196366923 cites W1686436548 @default.
• W3196366923 cites W1851350808 @default.
• W3196366923 cites W1887624773 @default.
• W3196366923 cites W1969376803 @default.
• W3196366923 cites W1983046030 @default.
• W3196366923 cites W1999651700 @default.
• W3196366923 cites W2003786134 @default.
• W3196366923 cites W2013913327 @default.
• W3196366923 cites W2017061308 @default.
• W3196366923 cites W2018631814 @default.
• W3196366923 cites W2019119862 @default.
• W3196366923 cites W2022180711 @default.
• W3196366923 cites W2022202732 @default.
• W3196366923 cites W2023384663 @default.
• W3196366923 cites W2030971064 @default.
• W3196366923 cites W2040267509 @default.
• W3196366923 cites W2044584051 @default.
• W3196366923 cites W2045828440 @default.
• W3196366923 cites W2050315451 @default.
• W3196366923 cites W2060126450 @default.
• W3196366923 cites W2066121036 @default.
• W3196366923 cites W2068400617 @default.
• W3196366923 cites W2080881039 @default.
• W3196366923 cites W2084570377 @default.
• W3196366923 cites W2085790896 @default.
• W3196366923 cites W2089673228 @default.
• W3196366923 cites W2095095800 @default.
• W3196366923 cites W2095104272 @default.
• W3196366923 cites W2096271255 @default.
• W3196366923 cites W2100323834 @default.
• W3196366923 cites W2100947872 @default.
• W3196366923 cites W2107931279 @default.
• W3196366923 cites W2118527243 @default.
• W3196366923 cites W2119304571 @default.
• W3196366923 cites W2130921983 @default.
• W3196366923 cites W2140415161 @default.
• W3196366923 cites W2156150085 @default.
• W3196366923 cites W2167854477 @default.
• W3196366923 cites W2171067477 @default.
• W3196366923 cites W2215326037 @default.
• W3196366923 cites W2219217139 @default.
• W3196366923 cites W2295776413 @default.
• W3196366923 cites W2319708691 @default.
• W3196366923 cites W2323776619 @default.
• W3196366923 cites W2329215684 @default.
• W3196366923 cites W2346951828 @default.
• W3196366923 cites W2404733137 @default.
• W3196366923 cites W2510187337 @default.
• W3196366923 cites W2562164234 @default.
• W3196366923 cites W2562440176 @default.
• W3196366923 cites W2569226759 @default.
• W3196366923 cites W2591780019 @default.
• W3196366923 cites W2758688326 @default.
• W3196366923 cites W2803993884 @default.
• W3196366923 cites W2890253186 @default.
• W3196366923 cites W2949974532 @default.
• W3196366923 cites W3003747161 @default.
• W3196366923 cites W3027228426 @default.
• W3196366923 cites W3031839880 @default.
• W3196366923 cites W3088990507 @default.
• W3196366923 cites W3092167072 @default.
• W3196366923 cites W3138244110 @default.
• W3196366923 cites W4229765253 @default.
• W3196366923 cites W4239559608 @default.
• W3196366923 cites W4255650505 @default.
• W3196366923 cites W824511325 @default.
• W3196366923 cites W1608244533 @default.
• W3196366923 doi "https://doi.org/10.2174/1570180818666210901125958" @default.
• W3196366923 hasPublicationYear "2022" @default.
• W3196366923 type Work @default.
• W3196366923 sameAs 3196366923 @default.
• W3196366923 citedByCount "1" @default.
• W3196366923 countsByYear W31963669232022 @default.
• W3196366923 crossrefType "journal-article" @default.
• W3196366923 hasAuthorship W3196366923A5009305444 @default.
• W3196366923 hasAuthorship W3196366923A5088699308 @default.
• W3196366923 hasConcept C134018914 @default.
• W3196366923 hasConcept C150903083 @default.
• W3196366923 hasConcept C166342909 @default.
• W3196366923 hasConcept C181199279 @default.
• W3196366923 hasConcept C185592680 @default.
• W3196366923 hasConcept C207001950 @default.
• W3196366923 hasConcept C2779284873 @default.
• W3196366923 hasConcept C2910068830 @default.
• W3196366923 hasConcept C55493867 @default.
• W3196366923 hasConcept C555293320 @default.
• W3196366923 hasConcept C71240020 @default.
• W3196366923 hasConcept C71924100 @default.
• W3196366923 hasConcept C86803240 @default.
• W3196366923 hasConcept C98274493 @default.
• W3196366923 hasConceptScore W3196366923C134018914 @default.

• next